Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Clin Implant Dent Relat Res ; 26(5): 1056-1066, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39113398

ABSTRACT

INTRODUCTION: The implant disease risk assessment (IDRA) tool was designed to assess an individual's risk of developing peri-implant diseases by evaluating and integrating multiple risk factors. This study aimed to evaluate the IDRA tool to determine the risk of developing peri-implant disease in patients rehabilitated with dental implants. METHODS: A retrospective observational cross-sectional study was conducted, collecting data from 92 patients with 92 selected dental implants. Data included the history of periodontitis, sites with bleeding on probing (BoP), teeth and/or implants with probing depths (PDs) ≥ 5 mm, alveolar bone loss relative to the patient's age, susceptibility to periodontitis, the frequency of supportive periodontal therapy (SPT), the distance from the restorative margin (RM) of the implant-supported prosthesis to the marginal bone crest (MBC), and factors related to the prosthesis itself. Additionally, the validated instrument periodontal risk assessment (PRA) was employed for comparison. Statistical analyses utilized Chi-square, Mann-Whitney, and ROC curve. RESULTS: Outcomes indicated that 62 implants (67.4%) were classified as high-risk. Among the IDRA parameters, history of periodontitis was the primary factor contributing to an increased risk (p < 0.001). IDRA revealed high sensitivity (100%) and low specificity (63%) (AUC = 0.685; 95% CI: 0.554-0.816; p = 0.047), and there was a low agreement between the IDRA and PRA tools (Kappa = 0.123; p = 0.014). The peri-implant disease developed in 16 implants with 5.44 (±2.50) years of follow-up, however, no significant association was observed between the high- and low-medium risk groups and the occurrence of peri-implant diseases. CONCLUSION: Most of the evaluated implants presented high IDRA risk. The IDRA tool exhibited high sensitivity and low specificity; no significant association was observed between the risk profile and the development of peri-implant diseases.


Subject(s)
Dental Implants , Humans , Retrospective Studies , Risk Assessment , Male , Female , Middle Aged , Cross-Sectional Studies , Dental Implants/adverse effects , Aged , Peri-Implantitis/etiology , Adult , Risk Factors , Periodontitis
2.
Braz Oral Res ; 38: e040, 2024.
Article in English | MEDLINE | ID: mdl-38747827

ABSTRACT

Peri-implant diseases, including peri-implant mucositis (PIM) and peri-implantitis, are a chronic inflammatory disorder triggered by bacterial biofilm in susceptible hosts. Potential risk factors for peri-implant diseases include smoking, dental plaque accumulation, poor oral hygiene, genetics, and absence of peri-implant keratinized mucosa. This cohort study aimed to evaluate the influence of patient-, implant-, and prosthetic-related factors on PIM and peri-implant bone loss (PBL) around dental implants after 1 year of loading. A total of 54 subjects (22 males and 32 females) were included in the study. Peri-implant clinical parameters were assessed and standardized periapical radiographs of each dental implant were obtained 15 days after the definitive prosthesis installation (baseline) and at 3, 6, and 12 months of follow-up. A total of 173 implants were evaluated. PIM affected 44.8% of the implants and no significant association was found between the investigated parameters and PIM incidence, except for type of implant connection. A significantly higher incidence of PIM (80.0%) was observed for implants with internal hexagon connection type after 1 year of follow-up (p = 0.015). Moreover, a mean PBL of 0.35 ± 1.89 mm was observed and no dental implant was affected by peri-implantitis after 1 year of function. No specific influence of patient, implant, or prosthetic factors on PBL was observed. No association was found between the occurrence of PIM/PBL and the patient-, implant-, and prosthetic-related factors investigated in this cohort study, except for the type of dental-implant connection.


Subject(s)
Alveolar Bone Loss , Dental Implants , Peri-Implantitis , Stomatitis , Humans , Female , Male , Middle Aged , Dental Implants/adverse effects , Alveolar Bone Loss/etiology , Adult , Risk Factors , Peri-Implantitis/etiology , Stomatitis/etiology , Time Factors , Aged , Cohort Studies , Statistics, Nonparametric , Young Adult
3.
J Prosthodont ; 33(7): 655-662, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38487989

ABSTRACT

PURPOSE: The objective of this retrospective study was to evaluate the effect of the interproximal contour of single external hexagon implant restorations on the prevalence of peri-implantitis. MATERIAL AND METHODS: Records of 96 patients and 148 external hexagon (EH) implants with time in function ranging from 1 to 17 years were included in the study. The most recent clinical and radiographic data were collected from records and the prevalence of peri-implantitis was defined according to the 2017 World Workshop on the Classification of Periodontal and Peri-implant Diseases and Conditions. Marginal bone level (MBL), emergence angle (EA), emergence profile (EP), and crown/implant platform horizontal ratio (CIHR) were obtained from periapical radiographs. Dichotomous variables at the patient- and implant level were compared with association tests. Mann-Whitney U-Test was performed to compare continuous quantitative values between the studied groups. Binomial logistic regression was conducted to identify risk indicators associated with the peri-implantitis event at the patient- and implant level, with the significance level set at 5% for all tests. RESULTS: Nineteen patients (19.2%) and 24 implants (16.2%) with a mean time in function of 5.0 ± 4.7 years were classified as having peri-implantitis. No statistically significant differences concerning gender, mean age, implant location in the jaw, or time in function were observed between patients with or without peri-implantitis (p > 0.05). Of 24 implants with peri-implantitis 10 (41.7%) displayed EA ≤ 30° (16.4%) while 14 (58.3%) presented EA > 30° with no statistical difference between the groups (p > 0.05). No statistically significant associations were identified between EA, EP, or CIHR and the prevalence of peri-implantitis. CONCLUSION: The findings seem to indicate that the EA, EP, and CIHR of single restorations over external hexagon implants are not associated with the presence of peri-implantitis. However, prospective studies with larger samples are required to better ascertain such an association in the long term.


Subject(s)
Peri-Implantitis , Humans , Peri-Implantitis/etiology , Peri-Implantitis/epidemiology , Retrospective Studies , Male , Female , Middle Aged , Prevalence , Adult , Aged , Dental Prosthesis Design
4.
Sci Rep ; 14(1): 627, 2024 01 05.
Article in English | MEDLINE | ID: mdl-38182598

ABSTRACT

This study evaluated the peri-implant tissues under normal conditions and under the influence of experimental peri-implantitis (EPI) in osseointegrated implants installed in the maxillae of rats treated with oncologic dosage of zoledronate. Twenty-eight senescent female rats underwent the extraction of the upper incisor and placement of a titanium dental implant (DI). After eight weeks was installated a transmucosal healing screw on DI. After nine weeks, the following groups were formed: VEH, ZOL, VEH-EPI and ZOL-EPI. From the 9th until the 19th, VEH and VEH-EPI groups received vehicle and ZOL and ZOL-EPI groups received zoledronate. At the 14th week, a cotton ligature was installed around the DI in VEH-EPI and ZOL-EPI groups to induce the EPI. At the 19th week, euthanasia was performed, and the maxillae were processed so that at the implanted sites were analyzed: histological aspects and the percentage of total bone tissue (PTBT) and non-vital bone tissue (PNVBT), along with TNFα, IL-1ß, VEGF, OCN and TRAP immunolabeling. ZOL group presented mild persistent peri-implant inflammation, higher PNVBT and TNFα and IL-1ß immunolabeling, but lower for VEGF, OCN and TRAP in comparison with VEH group. ZOL-EPI group exhibited exuberant peri-implant inflammation, higher PNVBT and TNFα and IL-1ß immunolabeling when compared with ZOL and VEH-EPI groups. Zoledronate disrupted peri-implant environment, causing mild persistent inflammation and increasing the quantity of non-vital bone tissue. Besides, associated with the EPI there were an exacerbated inflammation and even greater increase in the quantity of non-vital bone around the DI, which makes this condition a risk factor for medication-related osteonecrosis of the jaws.


Subject(s)
Bone-Anchored Prosthesis , Osteonecrosis , Peri-Implantitis , Female , Animals , Rats , Peri-Implantitis/etiology , Zoledronic Acid/adverse effects , Tumor Necrosis Factor-alpha , Vascular Endothelial Growth Factor A , Inflammation , Interleukin-1beta , Jaw
5.
Oral Maxillofac Surg ; 28(1): 331-336, 2024 Mar.
Article in English | MEDLINE | ID: mdl-36847879

ABSTRACT

OBJECTIVE: The present study aimed to assess the relationship between keratinized mucosa width and peri-implant diseases, namely peri-implant mucositis and peri-implantitis. MATERIALS AND METHODS: Ninety-one dental implants in function for ≥ 6 months from 40 partially or completely edentulous non-smoker subjects (24 females and 16 males) were evaluated clinically and radiographically. The width of keratinized mucosa, probing depth, plaque index, bleeding on probing, and marginal bone levels were assessed. Keratinized mucosa width was categorized as ≥ 2 mm or < 2 mm. RESULTS: There was no statistically significant association between keratinized buccal mucosa width and peri-implant mucositis or peri-implantitis (p ≥ 0.37). In the regression analysis, peri-implantitis was associated with longer implant function time (RR: 2.55, 95% CI: 1.25-11.81, p = 0.02) and implants in the maxilla (RR: 3.15, 95% CI: 1.61-14.93, p = 0.003). Mucositis was not associated with any of the factors analyzed. CONCLUSION: In conclusion, in the present sample, keratinized buccal mucosa width was not associated with peri-implant diseases, suggesting that a band of keratinized mucosa may not be necessary to maintain peri-implant health. Prospective studies are required to better understand its role in the maintenance of peri-implant health.


Subject(s)
Dental Implants , Mucositis , Peri-Implantitis , Male , Female , Humans , Peri-Implantitis/etiology , Retrospective Studies , Mouth Mucosa
6.
Expert Rev Med Devices ; 20(7): 557-573, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37228179

ABSTRACT

INTRODUCTION: Peri-implantitis is the leading cause of dental implant loss and is initiated by a polymicrobial dysbiotic biofilm formation on the implant surface. The destruction of peri-implant tissue by the host immune response and the low effectiveness of surgical or non-surgical treatments highlight the need for new strategies to prevent, modulate and/or eliminate biofilm formation on the implant surface. Currently, several surface modifications have been proposed using biomolecules, ions, antimicrobial agents, and topography alterations. AREAS COVERED: Initially, this review provides an overview of the etiopathogenesis and host- and material-dependent modulating factors of peri-implant disease. In addition, a critical discussion about the antimicrobial surface modification mechanisms and techniques employed to modify the titanium implant material is provided. Finally, we also considered the future perspectives on the development of antimicrobial surfaces to narrow the bridge between idea and product and favor the clinical application possibility. EXPERT OPINION: Antimicrobial surface modifications have demonstrated effective results; however, there is no consensus about the best modification strategy and in-depth information on the safety and longevity of the antimicrobial effect. Modified surfaces display recurring challenges such as short-term effectiveness, the burst release of drugs, cytotoxicity, and lack of reusability. Stimulus-responsive surfaces seem to be a promising strategy for a controlled and precise antimicrobial effect, and future research should focus on this technology and study it from models that better mimic clinical conditions.


Subject(s)
Anti-Infective Agents , Dental Implants , Peri-Implantitis , Humans , Biocompatible Materials/pharmacology , Dental Implants/adverse effects , Anti-Infective Agents/pharmacology , Peri-Implantitis/etiology , Peri-Implantitis/prevention & control , Titanium/pharmacology , Surface Properties , Biofilms
7.
Clin Oral Implants Res ; 34(6): 543-554, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36939434

ABSTRACT

OBJECTIVE: The aim of this study was to systematically analyze the influence of smoking on the incidence of peri-implantitis. MATERIALS AND METHODS: The search was performed in the National Library of Medicine (MEDLINE-PubMed), SCOPUS, EMBASE, and ISI Web of Science databases (finished on November 30, 2022). Systematic review and meta-analysis were conducted according to PRISMA statement. Prospective cohort studies that evaluate the incidence of peri-implantitis in smokers and non-smokers were included. Two authors independently searched for eligible studies, screened titles, and abstracts, did the full-text analysis, extracted data, and performed the risk-of-bias assessment. The results were summarized through random-effects meta-analyses. The GRADE method was used to determine the certainty of evidence. RESULTS: A total of 7 studies with 702 patients and 1959 implants were included for analysis. The meta-analysis revealed a significant difference between smokers and non-smokers for the risk of peri-implantitis in the implant-based (p < .0001) and patient-based analysis (p = .003). A strong association between smoking and the risk for peri-implantitis was verified at the implant level (RR: 2.04, 95% CI: 1.46-1.85) and the patient level (RR: 2.79, 95% CI: 1.42-5.50). CONCLUSIONS: Moderate certainty evidence suggests that smoking is associated with peri-implantitis compared to non-smoking at the patient and implant levels.


Subject(s)
Dental Implants , Peri-Implantitis , Humans , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Dental Implants/adverse effects , Incidence , Prospective Studies , Databases, Factual
8.
Clin Implant Dent Relat Res ; 25(2): 303-312, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36519351

ABSTRACT

OBJECTIVE: To prospectively evaluate the incidence of peri-implant diseases and the associated risk factors during 11 years of peri-implant maintenance therapy (PIMT). MATERIAL AND METHODS: A sample of 80 partially edentulous individuals rehabilitated with dental implants was invited to participate in a PIMT program (T1-prior to entering the PIMT program). After 11 years, 51 individuals remained regularly or irregularly adherent to PIMT (T2-last recall after 11 years) and were classified as regular (RC; n = 27) or irregular (IC; n = 24) compliers. Data of interest were analyzed using univariate and multivariate logistic regression analyses. RESULTS: The incidence of peri-implant mucositis and peri-implantitis observed at T2 in the IC group (70.8% and 37.5%, respectively) were significantly higher than those observed in the RC group (37.0% and 11.1%, respectively). The incidence of peri-implant diseases was mostly attributable to potentially modifiable risk factors, as such: RC group-PM (p = 0.013); IC group-high plaque index (p < 0.001), irregular compliance (p < 0.001), the presence of PM (p = 0.015) and periodontitis (p < 0.039). CONCLUSION: Regular compliance during PIMT had a strong effect in minimizing the incidence of peri-implant diseases. Increasing regular dental visits and improving oral hygiene would provide benefits for preventing peri-implant diseases.


Subject(s)
Dental Implants , Peri-Implantitis , Humans , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Peri-Implantitis/prevention & control , Follow-Up Studies , Dental Implants/adverse effects , Prospective Studies , Incidence
9.
Rio de Janeiro; s.n; 2023. 58 p. ilus, tab.
Thesis in Portuguese | BBO - Dentistry | ID: biblio-1530696

ABSTRACT

A peri-implantite é uma condição patológica associada ao biofilme peri-implantar que ocorre nos tecidos ao redor do implante dentário, caracterizado por inflamação e perda óssea progressiva. A peri-implantite desenvolve um infiltrado inflamatório intenso, oxidando partículas de lipoproteínas de baixa densidade (ox-LDL), conhecida por ter comportamento aterogênico. O objetivo da pesquisa foi fazer uma revisão sistemática sobre o papel do receptor 1 de LDL oxidado do tipo lectina (LOX-1) na patogênese da peri-implantite. Uma busca eletrônica sem restrição de idioma ou data de publicação foi realizada nas bases de dados MEDLINE|Pubmed, Cochrane CENTRAL e Embase, registros de protocolos e outras fontes até abril de 2023. A questão clínica e a estratégia de busca foram formuladas usando o método PECOD. Os critérios de elegibilidade incluíram estudos observacionais que avaliam o papel da LOX-1 na patogênese da peri-implantite. A qualidade dos estudos primários foi avaliada por "JBI Critical Appraisal Tools for Analytical Cross-Sectional Studies". A síntese dos resultados qualitativos seguiu a diretriz de relatórios SWiM e o GRADE foi usado para avaliar a qualidade das respostas nesta revisão sistemática (RS). Esta RS foi estruturada de acordo com a declaração PRISMA 2020. Foram selecionados 6 artigos, envolvendo 152 indivíduos, conforme os critérios de elegibilidade apresentando como resultados, o aumento e a participação do receptor 1 de LDL oxidado tipo lectina (LOX-1) em pacientes com periimplantite, além de mediar a expressão de metaloproteinase de matriz 2, contribuindo para a destruição tecidual progressiva na peri-implantite. Esta RS fornece evidências preliminares sobre a associação entre LOX-1 e peri-implantite. Reconhecendo as limitações deste estudo, observamos que a LOX-1 está envolvida na patogênese, além de ser um alvo potencial para o manejo da peri-implantite. (AU)


Peri-implantitis is a pathological condition associated with the peri-implant biofilm that occurs in the tissues around the dental implant, characterized by inflammation and progressive bone loss. Peri-implantitis develops an intense inflammatory infiltrate, oxidizing low-density lipoprotein particles (oX-LDL), known to have an atherogenic behavior. The objective of this research was to carry out a systematic review on the role of the lectin-type oxidized LDL receptor 1 (LOX-1) in the pathogenesis of peri-implantitis. An electronic search with no restriction on language or publication date was performed on MEDLINE|Pubmed, Cochrane CENTRAL, and Embase databases, protocol registries, and other sources through April 2023. The clinical question and search strategy were formulated using the method PECOD. Eligibility criteria included observational studies evaluating the role of LOX-1 in the pathogenesis of periimplantitis. The quality of the primary studies was assessed using the "JBI Critical Appraisal Tools for Analytical Cross-Sectional Studies". The synthesis of qualitative results followed the SWiM reporting guideline and GRADE was used to assess the quality of responses in this systematic review (SR). This SR was structured in accordance with the PRISMA 2020 statement. Six articles, involving 152 individuals, were selected according to the eligibility criteria, presenting as results, the increase and participation of oxidized lectin-type LDL receptor 1 (LOX-1) in patients with peri-implantitis, in addition to mediating the expression of matrix metalloproteinase 2, contributing to the progressive tissue destruction in periimplantitis. This SR provides preliminary early evidence on the association between LOX-1 and peri-implantitis. Recognizing the limitations of this study, we observed that LOX-1 is involved in the pathogenesis, in addition to being a potential target for the management of periimplantitis. (AU)


Subject(s)
Lectins, C-Type , Peri-Implantitis/drug therapy , Peri-Implantitis/etiology , Systematic Reviews as Topic
10.
Clin Oral Implants Res ; 33(12): 1212-1223, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36181373

ABSTRACT

OBJECTIVES: The aim of this cross-sectional study was to evaluate the effect of brushing discomfort (BD) on peri-implant health in sites exhibiting inadequate keratinized mucosa (KM) width. MATERIAL AND METHODS: Patients presenting with at least one implant exhibiting KM <2 mm and in function for ≥1 year were eligible for inclusion. BD was assessed with the visual analogue scale (VAS), and implants were classified into two groups: Absence (aBD; VAS = 0) or Presence (pBD; VAS > 0) of BD. Bleeding on probing (BoP), modified plaque index (mPI), probing depth (PD), clinical attachment level (CAL), suppuration (Sup), and marginal bone level (MBL) were recorded. Mann-Whitney, chi-square test, and a multilevel model were used for analysis. RESULTS: Fifty-nine patients with 155 dental implants were analyzed, of which 60 presented no BD, and 95 presented some level of BD. BoP, PD, CAL, and MBL were significantly higher in the pBD than in the aBD group (p < .05). The prevalence of peri-implant diseases at implant level was also higher in the pBD group than in the aBD group. However, after controlling for confounding factors, only mPI showed an effect on BoP. In addition, difficulty to perform oral hygiene was statistically higher in the pBD group. CONCLUSIONS: The findings of the present study suggest that although BD around implants exhibiting KM <2 mm did not influence tissue inflammation, it could represent a symptom of peri-implant diseases. Further clinical trials assessing the long-term effect of BD must be considered to better ascertain its effects on peri-implant health.


Subject(s)
Dental Implants , Mouth Mucosa , Toothbrushing , Humans , Cross-Sectional Studies , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Mouth Mucosa/pathology , Periodontal Index , Pain Management
11.
Periodontol 2000 ; 90(1): 224-235, 2022 10.
Article in English | MEDLINE | ID: mdl-35913455

ABSTRACT

Peri-implantitis is characterized by nonreversible and progressive loss of supporting bone and is associated with bleeding and/or suppuration on probing. Peri-implant disease is considered as the main etiologic factor related to implant failure. Peri-implant disease has a pathogenesis similar to that of periodontal disease, both being triggered by an inflammatory response to the biofilm accumulation. Although the prevalence of peri-implantitis has been evaluated by several clinical studies with different follow-ups, there are currently little data on the impact of implant location and the prevalence of peri-implantitis. The aim of this review, therefore, was to summarize the evidence concerning the prevalence of peri-implantitis in relation to implant location and associated risk predictors. Even though most studies evaluating the prevalence of peri-implantitis in relation to implant location are cross-sectional or retrospective, they suggest that the occurrence of peri-implantitis is most prevalent in the anterior regions of the maxilla and mandible. Moreover, it seems that there is a higher prevalence of peri-implantitis in the maxilla than in the mandible.


Subject(s)
Dental Implants , Peri-Implantitis , Cross-Sectional Studies , Dental Implants/adverse effects , Humans , Maxilla/pathology , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Peri-Implantitis/pathology , Retrospective Studies , Risk Factors
12.
Clin Oral Investig ; 26(7): 4835-4846, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35316410

ABSTRACT

OBJECTIVES: To investigate the association of cumulative smoking exposure and span since smoking cessation with the occurrence of peri-implantitis. METHODS: A sample of 350 individuals aged ≥ 35 years, with the presence of at least one osseointegrated implant functioning for > 5 years, were enrolled in the study. According to smoking habits, participants were categorized into 3 groups: non-smokers (NS; n = 212), former smokers (FC; n = 66), and current smokers (CS; n = 72). Complete peri-implant and periodontal examinations were evaluated. Associations between the occurrence of peri-implantitis and smoking habits, as well as potential confounders, were evaluated through univariate and multivariate analyses. RESULTS: The occurrence of peri-implantitis in the NS, FS, and CS groups was 18.2%, 19.7%, and 30.5%, respectively. A high prevalence of the overall number of cases with periodontitis (54.2%) was observed in the CS group when compared to the FS and NS groups. After adjusting for confounders, the odds ratio (OR) for the occurrence of peri-implantitis was 2.63 (1.39-6.77; p < 0.001) for CS compared to NS. There was a significant dose-response relationship between pack/year of smoking and the occurrence of peri-implantitis, as well as a significant decrease in the risk as the years of smoking cessation increased. CONCLUSIONS: The occurrence of peri-implantitis among CS was high. The cumulative smoking exposure in an incremental manner and the shorter smoking cessation span was directly associated with a higher risk for peri-implantitis. CLINICAL RELEVANCE: Educational and preventive strategies in general health services must attempt to reduce the adverse effects of cumulative smoking exposure and to explore the beneficial effects of smoking cessation on peri-implant status.


Subject(s)
Dental Implants , Peri-Implantitis , Smoking Cessation , Cross-Sectional Studies , Dental Implants/adverse effects , Humans , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Risk Factors , Smoking/adverse effects , Smoking/epidemiology
13.
J World Fed Orthod ; 11(1): 22-28, 2022 02.
Article in English | MEDLINE | ID: mdl-34906435

ABSTRACT

The study evaluated the clinical changes of orthodontic mini-implants (MI) inserted for the purpose of anchoring during orthodontic treatment. The null hypotheses were: 1-that there is no correlation between proximity of the MI to the root and peri-implantitis or mobility; 2-that peri-implantitis does not interfere with mobility; 3-that the pain is not related to mobility or peri-implantitis. Forty (40) patients were selected and the MI were evaluated for each patient. MI in the upper and lower arch were evaluated for a period of approximately 6 months with relationship to the distance MI - root, peri-implantitis, mobility, biological damage and pain through the analysis of periapical radiography and clinical/periodontal evaluation. The evaluations were performed out by means of scores and a correlation was made between the variables. No statistically significant differences were found between the upper and lower arch in the variables evaluated, except for the mobility that was more present in the lower arch (p = 0.0336). There was a correlation between peri-implantitis and mobility (p = 0.0003) and between pain and mobility (p = 0.0443). However, there was no correlation between a greater degree of peri-implantitis and greater mobility (p = 0.7054). In addition, the MI placed too close to the root showed peri-implantitis (p = 0.0142). The null hypotheses were rejected because there was a positive correlation between the analyzes. The placement of MI close to the root led to greater peri-implantitis. Patients who reported pain had greater mobility of the MI and peri-implantitis led to greater mobility.


Subject(s)
Dental Implants , Orthodontic Anchorage Procedures , Peri-Implantitis , Dental Implants/adverse effects , Humans , Orthodontic Anchorage Procedures/adverse effects , Pain , Peri-Implantitis/diagnostic imaging , Peri-Implantitis/etiology
14.
Clin Oral Investig ; 26(4): 3563-3572, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34859326

ABSTRACT

OBJECTIVE: The objective of this study was to evaluate the potential association between liver cirrhosis and peri-implant diseases, as well as the influence of different risk indicators on this association. METHODS: This case-control study included 64 cases with liver cirrhosis and 128 controls without liver diseases that presented the same socio-demographic and economic profile. The specific inclusion criteria were the following: aged group of 35-55 years and presenting at least one osseointegrated implant functioning for >5 years. A full-mouth peri-implant and periodontal examination was performed and risk variables were recorded. The association between risk variables and the occurrence of peri-implant diseases was tested through univariate analysis and multivariate logistic regression, stratified by alcohol status. Additionally, a mediation analysis was performed to examine the mediating effect of age with peri-implantitis. RESULTS: A high prevalence of peri-implantitis (29.7%) was observed among cases when compared to controls (18.0%). Individuals with cirrhosis presented ~2.5 higher chance of having peri-implantitis than controls (p<0.001). Significant variables associated with the occurrence of peri-implantitis in the final logistic model were the following: cirrhosis, alcohol use, age (>55 years), male sex, smoking, periodontitis, and number of ≤14. CONCLUSIONS: An important risk association between liver cirrhosis and peri-implantitis was reported. Future studies with a larger sample size controlling for the patient- and implant-related confounders are needed to better understand the link between peri-implantitis and liver cirrhosis. CLINICAL RELEVANCE: Cirrhosis individuals, age, and periodontitis, as well as alcohol use and smoking interaction, should be considered as potential risk indicators for peri-implantitis.


Subject(s)
Dental Implants , Peri-Implantitis , Aged , Case-Control Studies , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/epidemiology , Male , Middle Aged , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Risk Factors
15.
Einstein (Sao Paulo) ; 19: eRC5638, 2021.
Article in English, Portuguese | MEDLINE | ID: mdl-34037088

ABSTRACT

Peri-implant diseases, caused by bacteria from biofilm related to dental implants, are one of the main causes of late loss of implants. In this sense, peri-implant diseases are divided into peri-implant mucositis, when it affects only the soft tissues, and peri-implantitis, when there is a bone involvement, which can lead to the failure of dental implant therapy. Thus, biofilm removal is essential for peri-implant health, allowing long-term success in implant therapy. To improve the visualization of oral biofilm, which is usually transparent or colorless, disclosing agents have been routinely used. However, disclosing agents have allergenic potential and can cause staining extrinsically in restorative and prosthetic materials, leading to aesthetic impairment. Thus, the use of fluorescence has been studied as an alternative for visualization of oral biofilm. Therefore, this report describes the use of wide-field optical fluorescence for visualization of oral biofilm associated with implants and teeth, in a routine appointment and follow-up of a partially edentulous patient with peri-implant mucositis. In addition, this report showed wide-field optical fluorescence can be used in a clinical routine of care of patients with dental implants. In this sense, wide-field optical fluorescence allowed easy and immediate visualization of the mature oral biofilm for its adequate removal, evaluation of the quality of restoration to sealing of screw access-hole of implant and identification of cariogenic lesions, without risk of allergic reactions or staining of prostheses and restorations.


Subject(s)
Dental Implants , Mucositis , Peri-Implantitis , Biofilms , Dental Implants/adverse effects , Fluorescence , Humans , Peri-Implantitis/diagnostic imaging , Peri-Implantitis/etiology
16.
Article in English | MEDLINE | ID: mdl-33653646

ABSTRACT

OBJECTIVE: This systematic review aimed to evaluate the epidemiologic profile, screen for possible risk factors, and evaluate the spectrum of clinical characteristics of oral squamous cell carcinoma (OSCC) around dental implants (DIs). METHODS: The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta- Analyses statement. RESULTS: Thirty-three articles met the eligibility criteria. In total, the sample consisted of 63 patients, and women comprised the majority (55.5%). The mean age of patients was 66.7 years. Oral potentially malignant disorders were reported in 46% of patients, of which 65.5% occurred in women. The most common lesion found in women was oral lichen planus (52.6%). In 88.8% of patients OSCC around DIs occurred in the mandible, and the most common clinical appearance of the lesions was an exophytic mass (46%). Most of these lesions were initially treated as peri-implantitis. CONCLUSIONS: Most patients with OSCC around DIs were women without known risk factors. It is important to emphasize that these lesions may present clinical and radiographic features that could resemble peri-implantitis, which can lead to delay in the diagnosis and subsequent treatment.


Subject(s)
Carcinoma, Squamous Cell , Dental Implants , Head and Neck Neoplasms , Lichen Planus, Oral , Mouth Neoplasms , Peri-Implantitis , Aged , Carcinoma, Squamous Cell/epidemiology , Female , Humans , Mouth Neoplasms/epidemiology , Peri-Implantitis/epidemiology , Peri-Implantitis/etiology , Squamous Cell Carcinoma of Head and Neck
17.
Aust Dent J ; 66(1): 112-118, 2021 03.
Article in English | MEDLINE | ID: mdl-32939781

ABSTRACT

Despite the long-term survival rates of osseointegrated dental implants, several biological complications are known to affect the peri-implant tissues, such as peri-implant mucositis and peri-implantitis. Occasionally, the clinical features of these more common benign lesions, or others nonrelated to implants, might be similar to oral malignancies, leading to misdiagnosis. The objective of this study was to present a case series of oral cancer located adjacent to dental implants, aimed to identify the reasons for initial misinterpretation of diagnosis. Thirteen patients, 10 females and 3 males, aged 59 to 90, were assessed. Among the differential diagnoses established, a malignant or premalignant lesion was not considered in 10 out of the 13 patients. Peri-implantitis was the most common preliminary diagnosis, followed by fungal infection, viral infections, and traumatic ulcers. The meantime for the diagnosis of oral cancer was 21.5 months. The clinical presentation of peri-implant malignancy, such as ulceration, white and red plaques, and exophytic lesions, might mimic benign diseases that are more common in the oral cavity. Suspicious lesions with treatment failure that persist for more than 2 weeks require biopsy and histopathological analysis to establish an early definitive diagnosis to improve the prognosis and quality of life of the patients.


Subject(s)
Dental Implants , Mouth Neoplasms , Peri-Implantitis , Stomatitis , Aged , Aged, 80 and over , Dental Implants/adverse effects , Female , Humans , Male , Middle Aged , Mouth Neoplasms/diagnosis , Peri-Implantitis/diagnosis , Peri-Implantitis/etiology , Quality of Life , Stomatitis/diagnosis , Stomatitis/etiology
18.
Einstein (São Paulo, Online) ; 19: eRC5638, 2021. graf
Article in English | LILACS | ID: biblio-1249744

ABSTRACT

ABSTRACT Peri-implant diseases, caused by bacteria from biofilm related to dental implants, are one of the main causes of late loss of implants. In this sense, peri-implant diseases are divided into peri-implant mucositis, when it affects only the soft tissues, and peri-implantitis, when there is a bone involvement, which can lead to the failure of dental implant therapy. Thus, biofilm removal is essential for peri-implant health, allowing long-term success in implant therapy. To improve the visualization of oral biofilm, which is usually transparent or colorless, disclosing agents have been routinely used. However, disclosing agents have allergenic potential and can cause staining extrinsically in restorative and prosthetic materials, leading to aesthetic impairment. Thus, the use of fluorescence has been studied as an alternative for visualization of oral biofilm. Therefore, this report describes the use of wide-field optical fluorescence for visualization of oral biofilm associated with implants and teeth, in a routine appointment and follow-up of a partially edentulous patient with peri-implant mucositis. In addition, this report showed wide-field optical fluorescence can be used in a clinical routine of care of patients with dental implants. In this sense, wide-field optical fluorescence allowed easy and immediate visualization of the mature oral biofilm for its adequate removal, evaluation of the quality of restoration to sealing of screw access-hole of implant and identification of cariogenic lesions, without risk of allergic reactions or staining of prostheses and restorations.


RESUMO Doenças peri-implantares, causadas por bactérias de biofilme relacionadas a implantes dentários, são uma das principais causas de perda tardia de implantes. Nesse sentido, as doenças peri-implantares são divididas em mucosite peri-implantar, quando afeta apenas tecidos moles, e peri-implantite, quando há comprometimento ósseo, o que pode levar ao fracasso da terapia com implantes dentários. Assim, a remoção do biofilme é essencial para a saúde peri-implantar, permitindo sucesso a longo prazo na terapia com implantes. A fim de melhorar a visualização do biofilme oral, que geralmente é transparente ou incolor, agentes reveladores têm sido rotineiramente utilizados. No entanto, esses agentes têm potencial alergênico e podem causar manchas extrinsecamente em materiais restauradores e protéticos, levando a prejuízo estético. Assim, o uso da fluorescência tem sido estudado como alternativa para visualização do biofilme oral. Este relato descreve o uso da fluorescência óptica de campo amplo para visualização do biofilme oral associado a implantes e dentes em uma consulta de acompanhamento de rotina de uma paciente parcialmente edêntula com mucosite peri-implantar. Além disso, este relato evidenciou que a fluorescência óptica de campo amplo pode ser utilizada dentro da rotina clínica de atendimento de pacientes com implantes dentários. Nesse sentido, a fluorescência óptica de campo amplo permitiu a visualização fácil e imediata do biofilme oral maduro para sua remoção adequada, a avaliação da qualidade da restauração do selamento do orifício de acesso do parafuso do implante e a identificação de lesões cariogênicas, sem risco de reações alérgicas ou manchamento de próteses e restaurações.


Subject(s)
Humans , Dental Implants/adverse effects , Mucositis , Peri-Implantitis/etiology , Peri-Implantitis/diagnostic imaging , Biofilms , Fluorescence
20.
Braz Oral Res ; 33(suppl 1): e063, 2019.
Article in English | MEDLINE | ID: mdl-31576947

ABSTRACT

The objective of this paper was to evaluate the current evidence reporting on the prevalence of peri-implantitis and to determine the influencing factors. An electronic search for articles published until February 2019 reporting on the prevalence of peri-implantitis was performed in MEDLINE. Included criteria were published in international peer-reviewed journals, written in English language, reported on the prevalence of peri-implantitis, included implants with a minimum follow-up of one year after functional loading and used a clear definition for peri-implantitis and/or peri-implant mucositis with a clear cutoff for bone level changes according to the case definitions of Sanz and Chapple and Berglundh et al. 2018. Included papers were anaylized for factors affecting the reported prevalences for peri-implantitis. Twenty-five papers were included in the present review and a wide range for the reported prevalence of peri-implantitis was seen. Case definitions for peri-implantitis with various thresholds for bone loss together with the type of reporting on patient- or implant-level were the most significant factors that lead to a large variety of the occurrence of the disease. Additionally, follow-up time and the evaluation in a certain "convenience" population may have influenced the prevalence values. In conclusion, it can be stated that a wide range for reporting the prevalence of peri-implantitis can be found and no real estimation of the global burden of the disease can be made. Applying accurate case definitions for peri-implantitis is the most important factor for reporting the prevalence and should be strictly followed in future reports.


Subject(s)
Peri-Implantitis/epidemiology , Stomatitis/epidemiology , Humans , Peri-Implantitis/etiology , Prevalence , Risk Factors , Stomatitis/etiology
SELECTION OF CITATIONS
SEARCH DETAIL